Literature DB >> 29314142

Retinoblastoma, the visible CNS tumor: A review.

Helen Dimaras1,2,3,4,5, Timothy W Corson6,7,8,9.   

Abstract

The pediatric ocular cancer retinoblastoma is the only central nervous system (CNS) tumor readily observed without specialized equipment: it can be seen by, and in, the naked eye. This accessibility enables unique imaging modalities. Here, we review this cancer for a neuroscience audience, highlighting these clinical and research imaging options, including fundus imaging, optical coherence tomography, ultrasound, and magnetic resonance imaging. We also discuss the subtype of retinoblastoma driven by the MYCN oncogene more commonly associated with neuroblastoma, and consider trilateral retinoblastoma, in which an intracranial tumor arises along with ocular tumors in patients with germline RB1 gene mutations. Retinoblastoma research and clinical care can offer insights applicable to CNS malignancies, and also benefit from approaches developed elsewhere in the CNS.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  MYCN; cancer genetics; neuroimaging; optical coherence tomography; pediatric cancer; pineoblastoma

Mesh:

Year:  2018        PMID: 29314142      PMCID: PMC6034991          DOI: 10.1002/jnr.24213

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  149 in total

1.  The evaluation and current concept of retinoblastoma therapy.

Authors:  A B REESE; R M ELLSWORTH
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1963 Mar-Apr

Review 2.  Diagnostic Ophthalmic Ultrasound for Radiologists.

Authors:  Cynthia J Kendall; Thomas C Prager; Han Cheng; Dan Gombos; Rosa A Tang; Jade S Schiffman
Journal:  Neuroimaging Clin N Am       Date:  2015-08       Impact factor: 2.264

Review 3.  Clues to the cells of origin in retinoblastoma.

Authors:  M O Tso
Journal:  Int Ophthalmol Clin       Date:  1980

4.  Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma.

Authors:  T Kivelä
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

Review 5.  MRI of retinoblastoma.

Authors:  A A K A Razek; S Elkhamary
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

6.  [Diagnosis of retinoblastoma using ultrasound].

Authors:  A Novotný; J Krásný
Journal:  Cas Lek Cesk       Date:  1990-03-23

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 8.  Neuroblastoma and MYCN.

Authors:  Miller Huang; William A Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

9.  Detection of optic nerve disease in retinoblastoma by use of spectral domain optical coherence tomography.

Authors:  Yacoub A Yousef; Manohar Shroff; William Halliday; Brenda L Gallie; Elise Héon
Journal:  J AAPOS       Date:  2012-10       Impact factor: 1.220

10.  Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

Authors:  B L Gallie; R M Ellsworth; D H Abramson; R A Phillips
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more
  35 in total

1.  Clinicopathological analysis of 719 pediatric and adolescents' ocular tumors and tumor-like lesions: a retrospective study from 2000 to 2018 in China.

Authors:  Xi-Zhe Dai; Lin-Yan Wang; Yi Shan; Jiang Qian; Kang Xue; Juan Ye
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  A tumor suppressor Retinoblastoma1 is essential for embryonic development in the sea urchin.

Authors:  Ana Fernandez-Nicolas; Derek Xu; Mamiko Yajima
Journal:  Dev Dyn       Date:  2019-10-01       Impact factor: 3.780

3.  An atypical clinical/radiological presentation of Retinoblastoma in a 4-year-old child: A case report & educational lessons from Syria.

Authors:  Munawar Hraib; Amjad Mhanna; Bushra Bayerly; Abdulmoneim Ghanem; Zuheir Alshehabi
Journal:  Ann Med Surg (Lond)       Date:  2022-05-18

4.  Clinical Features of Children with Retinoblastoma and Neuroblastoma.

Authors:  Xiaolian Fang; Huanmin Wang; Xiaoli Ma; Yongli Guo; Wei Yang; Shoulong Hu; Yue Qiu; Junyang Zhao; Xin Ni
Journal:  J Ophthalmol       Date:  2020-07-10       Impact factor: 1.909

5.  The top 10 retinoblastoma research priorities in Canada as determined by patients, clinicians and researchers: a patient-oriented priority-setting partnership.

Authors:  Kaitlyn Flegg; Maxwell J Gelkopf; Sarah A Johnson; Helen Dimaras
Journal:  CMAJ Open       Date:  2020-06-09

6.  Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor.

Authors:  Zengchun Hu; Chuandong Cheng; Yue Wang; Tianrui Chen; Junhong Tu; Chaoshi Niu; Rong Xing; Yang Wang; Yinghui Xu
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

7.  lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p.

Authors:  Yuxin Zhao; Zhaoxia Wang; Meili Gao; Xuehong Wang; Hui Feng; Yuanyuan Cui; Xia Tian
Journal:  Open Med (Wars)       Date:  2021-06-24

8.  Patient knowledge, experiences and preferences regarding retinoblastoma and research: A qualitative study.

Authors:  Catherine Moses; Kaitlyn Flegg; Helen Dimaras
Journal:  Health Expect       Date:  2020-02-29       Impact factor: 3.377

Review 9.  Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis.

Authors:  Jiali Wu; Dashi Qian; Xiaodong Sun
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

10.  Long Non-Coding RNA TP53TG1 Upregulates SHCBP1 to Promote Retinoblastoma Progression by Sponging miR-33b.

Authors:  Hongyi Wang; Zhen Zhang; Yue Zhang; Shihai Liu; Li Li
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.